This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

North America, Europe & Asia Pacific Legal Cannabis Market

Market Insights on North America, Europe & Asia Pacific Legal Cannabis covering sales outlook, demand forecast & up-to-date key trends

North America, Europe & Asia Pacific Legal Cannabis Market By Source, Derivates, End-Use & region - Forecast 2022 - 2032

North America, Europe & Asia Pacific Legal Cannabis Market Outlook (2022-2032)

[324 Pages Report] The North America, Europe & Asia Pacific legal cannabis market is expected to reach a market valuation of US$ 18.42 Billion by the year 2022, accelerating with a moderate CAGR of 25.3% by 2022-2032. North America, Europe & Asia Pacific legal cannabis market size is anticipated to be valued at about US$ 175.7 Billion by 2032 end.

As consumers switch from conventional treatment approaches to cannabis-based treatments, there has been an increase in the usage of marijuana, primarily for medicinal purposes, which is supporting the North America, Europe & Asia Pacific legal cannabis market growth overall. The COVID-19 epidemic has also had a significant impact on the market because a state-wide lockdown has hampered production and imposed import/export restrictions, which have decreased overall sales of North America, Europe & Asia Pacific legal cannabis.

Attributes

Value

North America, Europe & Asia Pacific Legal Cannabis Market Size (2022)

US$ 18.42 Billion

North America, Europe & Asia Pacific Legal Cannabis Market Projected Size (2032)

US$ 175.7 Billion

North America, Europe & Asia Pacific Legal Cannabis Market Value CAGR (2022-2032)

25.3%

The usage of hemp and marijuana in a range of industries, including food and beverage production, pharmaceuticals, nutraceuticals, and personal care and cosmetics, has facilitated the rise in the demand for North America, Europe & Asia Pacific legal cannabis. Additionally, over the forecast period, businesses are anticipated to use more cannabis and its variants as raw materials to create their goods, fueling North America, Europe & Asia Pacific legal cannabis market growth.

As per the North America, Europe & Asia Pacific legal cannabis market study, legalizing marijuana for recreational use will greatly boost the economy and assist create new job opportunities. The industries that will gain from legalization include tourism, real estate, banking, food, and transportation. For instance, several banks have started to approve loans for marijuana firms, which would flourish if marijuana for adult use is legalized. As a result, the imminent legalization of cannabis for recreational purposes is anticipated to raise demand for it and decrease the black market for it.

Customize this Report

Let us know your requirement to get
100% FREE customization

What are the Major Driving Factors for the North America, Europe & Asia Pacific Legal Cannabis Market?

In the upcoming years, the demand for medical marijuana is anticipated to increase due to the expanding number of states that have legalized the drug and the rising demand from both medical and recreational uses. This is expected to drive the demand for North America, Europe & Asia Pacific legal cannabis.

Demand for North America, Europe & Asia Pacific legal cannabis is anticipated to rise during the anticipated time frame as a result of more research and development being done.

What are the Existing Challenges for the North America, Europe & Asia Pacific Legal Cannabis Market Future Trends?

In several parts of North America, Africa, Australia, Europe, and South America, marijuana is nominally recognized as a drug and is permitted for medical usage. But the majority of Middle Eastern and Asian nations continue to forbid it. Consumption, possession, purchase, or sale of the commodity is illegal and is regarded as a crime in developing nations like Japan, India, and Korea. As a result, it is anticipated that the legal environment for these items will prevent the North America, Europe & Asia Pacific legal cannabis industry from reaching its full growth potential. Growth is also anticipated to be constrained by adverse effects including cognitive impairment linked to its usage as medicine.

The global pandemic has significantly hampered the North America, Europe & Asia Pacific legal cannabis market growth. The North America, Europe & Asia Pacific legal cannabis market has been hit by a number of major challenges, including trade restrictions, the adoption of a lockdown in several important nations, and supply chain interruptions.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Comparative View of Adjacent North America, Europe & Asia Pacific Legal Cannabis Market

North America, Europe & Asia Pacific Legal Cannabis Market:

Attributes

North America, Europe & Asia Pacific Legal Cannabis Market

CAGR (2022 to 2032)

25.3%

Market Value (2022)

US$ 18.42 Billion

Growth Factor

Rising demand for cannabis for medical applications to augment North America, Europe & Asia Pacific legal cannabis market growth.

Future Opportunities

The usage of hemp and marijuana in a range of industries, including food and beverage production, pharmaceuticals, nutraceuticals, and personal care and cosmetics, has facilitated growth.

Market Trends

Tight rules make it more challenging for producers to set up a practical and legal path for the production and marketing of products made from cannabis, such cannabidiol.

Cannabis Testing Market:

Attributes

Cannabis Testing Market

CAGR (2022 to 2032)

13.4%

Market Value (2022)

US$ 962 Million

Growth Factor

Legalizing cannabis for medical purposes and expanding the number of cannabis testing facilities is driving the market.

Future Opportunities

The cannabis testing industry is anticipated to grow rapidly in emerging nations throughout LATAM (Latin America) and the MEA (the Middle East and Africa).

Market Trends

Major challenges that are anticipated to impede market expansion include a lack of standardization in rules and regulations, excessive expenses, and insufficient staff.

Drug Screening Market:

Attributes

Drug Screening Market

CAGR (2022 to 2032)

16.8%

Market Value (2022)

US$ 5.3 Billion

Growth Factor

Due to rising drug and alcohol use, strict legislation requiring drug and alcohol testing, and an increase in regulatory approvals for drug screening goods and services, this market is expected to rise.

Future Opportunities

The development of drug screening goods & services for use on the road will continue to grow, contributing to the growth of the industry as a whole.

Market Trends

The expansion of this market may be limited to some extent by restrictions on employment drug testing and alcohol usage in Islamic nations.

Cannabis legalization is frequently regarded from two perspectives, and it has historically been greeted with suspicion because to concerns about potential abuse. People are now able to use drugs safely and recognize the medical benefits of cannabis thanks to its legalization. Because of this, numerous nations are increasingly legalizing its use all around the world. Even though the majority of the world's nations have not yet authorized recreational use, attitudes toward its use and sale have softened with time. This has caused its use to become more and more common, which is causing the North America, Europe & Asia Pacific legal cannabis market to rise.

Over 70.0 percent of all revenues in 2021 came from marijuana, which is also projected to grow at the quickest rate during the forecasted period. Smoking marijuana is less expensive and has a more rapid onset of effects than oils or tinctures; it is typically preferred for flowers. They are also well-known for recreational use, and as the state government officials finish the legalization process, leading the North America, Europe & Asia Pacific legal cannabis market is expected to expand profitably.

Category-wise Insights for Global North America, Europe & Asia Pacific Legal Cannabis Market

Which Type of North America, Europe & Asia Pacific Legal Cannabis Derivatives are Most Preferred in the Global Market?

The highest North America, Europe & Asia Pacific legal cannabis market share in 2021—more than 65.0 percent—went to CBD. Since legalization, there has been a considerable increase in the use of medical cannabis, and the majority of products used for therapeutic purposes contain CBD.

Demand for North America, Europe & Asia Pacific legal cannabis is also anticipated to increase throughout the forecasted period as hemp-derived cannabidiol (CBD) is increasingly used in skincare and cosmetics, gummies, beverages, pet food, capsules, and dog treats.

Which Segment of the North America, Europe & Asia Pacific Legal Cannabis Market on the Basis of End Use is Performing Better?

In 2021, the medical use segment's North America, Europe & Asia Pacific legal cannabis revenue share was above 65.0 percent, which was the highest. Cannabis use has increased dramatically as more places legalize it, particularly in North America where most states have approved medical use of the drug. This is related to the product's expanding use in the treatment of insomnia, anxiety disorders, and chronic pain. Furthermore, the expansion of the segment is being aided by rising practitioner knowledge.

Due to the relaxation of cannabis use legislation, the Asia Pacific region of the North America, Europe & Asia Pacific legal cannabis market is anticipated to see a large increase in the recreational use segment.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Regional Analysis of the North America, Europe & Asia Pacific Legal Cannabis Market

How North America, Europe & Asia Pacific Legal Cannabis Market Share is performing in Asia Pacific?

Asia-Pacific region of the North America, Europe & Asia Pacific legal cannabis market is anticipated to experience the fastest growth during the anticipated time. Growth is anticipated to be boosted by the increasing legalization and supportive laws for the use of cannabis and its derivative products in various nations. For instance, Thailand delisted marijuana from its list of prohibited substances in 2020. This is expected to lead to an increase in hemp and marijuana use across the nation.

What is the Performance of North America, Europe & Asia Pacific Legal Cannabis Market in the North American Region?

Highest North America, Europe & Asia Pacific legal cannabis market share in 2020 belonged to North America, which was worth USD 19.78 billion. As of July 2019, it was allowed for recreational use in eleven states and the District of Columbia. All state medical hemp legislation in the United States accepted it as a treatment or medication for ailments like cancer, Alzheimer's disease, anorexia, arthritis, chronic pain, epilepsy, and post-traumatic stress disorder. By taking the lead in the international legalization of marijuana, Canada has recently become recognized as a flag-bearer nation. Additionally, the number of its farmers in the U.S. has substantially expanded, supporting its use and consumption. This is expected to boost sales of North America, Europe & Asia Pacific legal cannabis and give local businesses access to new revenue streams.

How North America, Europe & Asia Pacific Legal Cannabis Market Share is performing in Europe?

Europe is the second-largest region in the North America, Europe & Asia Pacific legal cannabis market after the United States because of its progressive laws and rising medicinal marijuana use. Trials have shown that medicinal marijuana is helpful in some European nations, where it is being used lawfully in healthcare settings to treat everything from cancer to appetite stimulants for those with AIDS-related disease.

The demand for North America, Europe & Asia Pacific legal cannabis is also anticipated to rise quickly as a result of changes in government policies. The necessary legislation is very new in many nations; the Greek government legalised medical marijuana in 2018, the same year as the United Kingdom. As a result, it is anticipated that increased use of the product for medical purposes will increase regional sales.

Competitive Landscape for the North America, Europe & Asia Pacific Legal Cannabis Market

As the tide of legalization slowly sweeps the world, the North America, Europe & Asia Pacific legal cannabis industry remains fiercely competitive and vibrantly dynamic. New collaborations and expansions are already under way. Younger consumers are predicted to develop more complex patterns of recreational consumption and take greater risks when experimenting with various product variants. Therefore, a change from flower/bud to more processed formats including edibles, oils, and topical applications is being caused by the rapidly growing popularity of recreational use, and this movement has been adequately reacted to by important North America, Europe & Asia Pacific legal cannabis market players.

Recent Developments in Global North America, Europe & Asia Pacific Legal Cannabis Market

The world's largest cannabis company will be formed through the combination of Aphria Inc. and Tilray, Inc. (Canada), according to a definitive agreement that was signed in December 2020. The combined company would have a full line of branded Cannabis 2.0 goods in Canada, supported by low-cost facilities for cultivation, processing, and manufacturing.

One of the biggest independent craft breweries, SW Brewing Company, LLC (US), was acquired by Aphria Inc. in November 2020. SweetWater provides complementing cannabis lifestyle brands, which would aid Aphria in broadening the scope of its product line.

Startup Ecosystem in the Global North America, Europe & Asia Pacific Legal Cannabis Market

Olla, founded in 2019, which aspires to be the WordPress of online cannabis retailers, offers a completely configurable interface that enables businesses to create custom websites without having to give up important web space to another provider's branding. Olla aims to make the process of ordering cannabis online simpler for everyone. It was created with a mobile-first attitude and has open connections with cannabis POS and CRM systems like Flow Hub and Green Bits. Olla-using retailers report an order completion rate of 88 percent, a fivefold increase in order volume, and 92 percent of customers placing mobile orders.

North America, Europe & Asia Pacific Legal Cannabis Market Key Players

  • Aurora Cannabis
  • Canopy Growth Corporation
  • Tilray
  • VIVO Cannabis Inc.
  • GW Pharmaceuticals
  • Lexaria Bioscience Corp.
  • Bod Australia
  • Organigram Holdings Inc.
  • The Cronos Group
  • AusCann Group Holdings Ltd.
  • Cann Group Limited
  • THC Global Group Limited
  • Althea Group
  • Zelira Therapeutics
  • MGC Pharma

North America, Europe & Asia Pacific Legal Cannabis Market by Segmentation

By Source:

  • Marijuana
    • Flower
    • Oil & Tinctures
  • Hemp
    • Hemp CBD
    • Supplements
    • Industrial Hemp

By Derivates:

  • CBD
  • THC
  • Others

By End-Use:

  • Medical Use
    • Cancer
    • Chronic Pain
    • Depression and Anxiety
    • Arthritis
    • Diabetes
    • Glaucoma
    • Migraines
    • Epilepsy
    • Multiple Sclerosis
    • AIDS
    • Amyotrophic Lateral Sclerosis
    • Alzheimer’s
    • Post-Traumatic Stress Disorder (PTSD)
    • Parkinson's
    • Tourette’s
    • Others
  • Recreational Use
  • Industrial Use
    • Textile
    • Non-textile

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa

Frequently Asked Questions

The North America, Europe & Asia Pacific Legal Cannabis market is expected to grow at 25.3% CAGR over 2022-2032.

The North America, Europe & Asia Pacific Legal Cannabis market is estimated to be around US$ 18.42 Billion in 2022.

The North America, Europe & Asia Pacific Legal Cannabis market is anticipated to reach a valuation of US$ 175.7 Billion by 2032.

In 2021, the medical use segment's revenue share was above 65.0 percent, which was the highest.

North America accounted for the greatest revenue share of over 80.0 percent in 2021, and it is anticipated that it would continue to grow quickly during the forecasted period.

Table of Content

1. Executive Summary

    1.1. North America, Europe & Asia Pacific Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Product Life Cycle Analysis

    3.5. Supply Chain Analysis

        3.5.1. Supply Side Participants and their Roles

            3.5.1.1. Producers

            3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)

            3.5.1.3. Wholesalers and Distributors

        3.5.2. Value Added and Value Created at Node in the Supply Chain

        3.5.3. List of Raw Material Suppliers

        3.5.4. List of Existing and Potential Buyer’s

    3.6. Investment Feasibility Matrix

    3.7. Value Chain Analysis

        3.7.1. Profit Margin Analysis

        3.7.2. Wholesalers and Distributors

        3.7.3. Retailers

    3.8. PESTLE and Porter’s Analysis

    3.9. Regulatory Landscape

        3.9.1. By Key Regions

        3.9.2. By Key Countries

    3.10. Regional Parent Market Outlook

    3.11. Production and Consumption Statistics

    3.12. Import and Export Statistics

4. North America, Europe & Asia Pacific Legal Cannabis Market Analysis 2017-2021 and Forecast, 2022-2032

    4.1. Historical Market Size Value (US$ Mn) & Volume (Tons) Analysis, 2017-2021

    4.2. Current and Future Market Size Value (US$ Mn) & Volume (Tons) Projections, 2022-2032

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. North America, Europe & Asia Pacific Legal Cannabis Market Analysis 2017-2021 and Forecast 2022-2032, By Source Type

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Mn) & Volume (Tons) Analysis By Source Type, 2017-2021

    5.3. Current and Future Market Size Value (US$ Mn) & Volume (Tons) Analysis and Forecast By Source Type, 2022-2032

        5.3.1. Marijuana

            5.3.1.1. Flower

            5.3.1.2. Oil & Tinctures

        5.3.2. Hemp

            5.3.2.1. Hemp CBD

            5.3.2.2. Supplements

            5.3.2.3. Industrial Hemp

    5.4. Y-o-Y Growth Trend Analysis By Source Type, 2017-2021

    5.5. Absolute $ Opportunity Analysis By Source Type, 2022-2032

6. North America, Europe & Asia Pacific Legal Cannabis Market Analysis 2017-2021 and Forecast 2022-2032, By Derivatives

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Mn) & Volume (Tons) Analysis By Derivatives, 2017-2021

    6.3. Current and Future Market Size Value (US$ Mn) & Volume (Tons) Analysis and Forecast By Derivatives, 2022-2032

        6.3.1. CBD

        6.3.2. THC

        6.3.3. Others

    6.4. Y-o-Y Growth Trend Analysis By Derivatives, 2017-2021

    6.5. Absolute $ Opportunity Analysis By Derivatives, 2022-2032

7. North America, Europe & Asia Pacific Legal Cannabis Market Analysis 2017-2021 and Forecast 2022-2032, By End-use

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Mn) & Volume (Tons) Analysis By End-use, 2017-2021

    7.3. Current and Future Market Size Value (US$ Mn) & Volume (Tons) Analysis and Forecast By End-use, 2022-2032

        7.3.1. Medical Use

            7.3.1.1. Cancer

            7.3.1.2. Chronic Pain

            7.3.1.3. Depression and Anxiety

            7.3.1.4. Arthritis

            7.3.1.5. Diabetes

            7.3.1.6. Glaucoma

            7.3.1.7. Migraines

            7.3.1.8. Epilepsy

            7.3.1.9. Multiple Sclerosis

            7.3.1.10. AIDS

        7.3.2. Recreational Use

        7.3.3. Industrial Use

            7.3.3.1. Textile

            7.3.3.2. Non-textile

    7.4. Y-o-Y Growth Trend Analysis By End-use, 2017-2021

    7.5. Absolute $ Opportunity Analysis By End-use, 2022-2032

8. North America, Europe & Asia Pacific Legal Cannabis Market Analysis 2017-2021 and Forecast 2022-2032, By Region

    8.1. Introduction

    8.2. Historical Market Size Value (US$ Mn) & Volume (Tons) Analysis By Region, 2017-2021

    8.3. Current Market Size Value (US$ Mn) & Volume (Tons) Analysis and Forecast By Region, 2022-2032

        8.3.1. North America

        8.3.2. Europe

        8.3.3. Asia Pacific

    8.4. Market Attractiveness Analysis By Region

9. North America Legal Cannabis Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    9.1. Historical Market Size Value (US$ Mn) & Volume (Tons) Trend Analysis By Market Taxonomy, 2017-2021

    9.2. Market Size Value (US$ Mn) & Volume (Tons) Forecast By Market Taxonomy, 2022-2032

        9.2.1. By Country

            9.2.1.1. U.S.

            9.2.1.2. Canada

        9.2.2. By Source Type

        9.2.3. By Derivatives

        9.2.4. By End-use

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Source Type

        9.3.3. By Derivatives

        9.3.4. By End-use

    9.4. Key Takeaways

10. Europe Legal Cannabis Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    10.1. Historical Market Size Value (US$ Mn) & Volume (Tons) Trend Analysis By Market Taxonomy, 2017-2021

    10.2. Market Size Value (US$ Mn) & Volume (Tons) Forecast By Market Taxonomy, 2022-2032

        10.2.1. By Country

            10.2.1.1. Czech Republic

            10.2.1.2. U.K.

            10.2.1.3. France

            10.2.1.4. Poland

            10.2.1.5. Italy

            10.2.1.6. Rest of Europe

        10.2.2. By Source Type

        10.2.3. By Derivatives

        10.2.4. By End-use

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Source Type

        10.3.3. By Derivatives

        10.3.4. By End-use

    10.4. Key Takeaways

11. Asia Pacific Legal Cannabis Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    11.1. Historical Market Size Value (US$ Mn) & Volume (Tons) Trend Analysis By Market Taxonomy, 2017-2021

    11.2. Market Size Value (US$ Mn) & Volume (Tons) Forecast By Market Taxonomy, 2022-2032

        11.2.1. By Country

            11.2.1.1. China

            11.2.1.2. Japan

            11.2.1.3. Australia

            11.2.1.4. New Zealand

            11.2.1.5. Rest of APAC

        11.2.2. By Source Type

        11.2.3. By Derivatives

        11.2.4. By End-use

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Source Type

        11.3.3. By Derivatives

        11.3.4. By End-use

    11.4. Key Takeaways

12. Key Countries Legal Cannabis Market Analysis

    12.1. U.S.

        12.1.1. Pricing Analysis

        12.1.2. Market Share Analysis, 2021

            12.1.2.1. By Source Type

            12.1.2.2. By Derivatives

            12.1.2.3. By End-use

    12.2. Canada

        12.2.1. Pricing Analysis

        12.2.2. Market Share Analysis, 2021

            12.2.2.1. By Source Type

            12.2.2.2. By Derivatives

            12.2.2.3. By End-use

    12.3. Czech Republic

        12.3.1. Pricing Analysis

        12.3.2. Market Share Analysis, 2021

            12.3.2.1. By Source Type

            12.3.2.2. By Derivatives

            12.3.2.3. By End-use

    12.4. U.K.

        12.4.1. Pricing Analysis

        12.4.2. Market Share Analysis, 2021

            12.4.2.1. By Source Type

            12.4.2.2. By Derivatives

            12.4.2.3. By End-use

    12.5. France

        12.5.1. Pricing Analysis

        12.5.2. Market Share Analysis, 2021

            12.5.2.1. By Source Type

            12.5.2.2. By Derivatives

            12.5.2.3. By End-use

    12.6. Poland

        12.6.1. Pricing Analysis

        12.6.2. Market Share Analysis, 2021

            12.6.2.1. By Source Type

            12.6.2.2. By Derivatives

            12.6.2.3. By End-use

    12.7. Italy

        12.7.1. Pricing Analysis

        12.7.2. Market Share Analysis, 2021

            12.7.2.1. By Source Type

            12.7.2.2. By Derivatives

            12.7.2.3. By End-use

    12.8. Rest of Europe

        12.8.1. Pricing Analysis

        12.8.2. Market Share Analysis, 2021

            12.8.2.1. By Source Type

            12.8.2.2. By Derivatives

            12.8.2.3. By End-use

    12.9. China

        12.9.1. Pricing Analysis

        12.9.2. Market Share Analysis, 2021

            12.9.2.1. By Source Type

            12.9.2.2. By Derivatives

            12.9.2.3. By End-use

    12.10. Japan

        12.10.1. Pricing Analysis

        12.10.2. Market Share Analysis, 2021

            12.10.2.1. By Source Type

            12.10.2.2. By Derivatives

            12.10.2.3. By End-use

    12.11. Australia

        12.11.1. Pricing Analysis

        12.11.2. Market Share Analysis, 2021

            12.11.2.1. By Source Type

            12.11.2.2. By Derivatives

            12.11.2.3. By End-use

    12.12. New Zealand

        12.12.1. Pricing Analysis

        12.12.2. Market Share Analysis, 2021

            12.12.2.1. By Source Type

            12.12.2.2. By Derivatives

            12.12.2.3. By End-use

    12.13. Rest of APAC

        12.13.1. Pricing Analysis

        12.13.2. Market Share Analysis, 2021

            12.13.2.1. By Source Type

            12.13.2.2. By Derivatives

            12.13.2.3. By End-use

13. Market Structure Analysis

    13.1. Competition Dashboard

    13.2. Competition Benchmarking

    13.3. Market Share Analysis of Top Players

        13.3.1. By Regional

        13.3.2. By Source Type

        13.3.3. By Derivatives

        13.3.4. By End-use

14. Competition Analysis

    14.1. Competition Deep Dive

        14.1.1. Aurora Cannabis

            14.1.1.1. Overview

            14.1.1.2. Product Portfolio

            14.1.1.3. Profitability by Market Segments

            14.1.1.4. Sales Footprint

            14.1.1.5. Strategy Overview

                14.1.1.5.1. Marketing Strategy

                14.1.1.5.2. Product Strategy

                14.1.1.5.3. Channel Strategy

        14.1.2. Tilray

            14.1.2.1. Overview

            14.1.2.2. Product Portfolio

            14.1.2.3. Profitability by Market Segments

            14.1.2.4. Sales Footprint

            14.1.2.5. Strategy Overview

                14.1.2.5.1. Marketing Strategy

                14.1.2.5.2. Product Strategy

                14.1.2.5.3. Channel Strategy

        14.1.3. GW Pharmaceuticals

            14.1.3.1. Overview

            14.1.3.2. Product Portfolio

            14.1.3.3. Profitability by Market Segments

            14.1.3.4. Sales Footprint

            14.1.3.5. Strategy Overview

                14.1.3.5.1. Marketing Strategy

                14.1.3.5.2. Product Strategy

                14.1.3.5.3. Channel Strategy

        14.1.4. Canopy Growth Corporation

            14.1.4.1. Overview

            14.1.4.2. Product Portfolio

            14.1.4.3. Profitability by Market Segments

            14.1.4.4. Sales Footprint

            14.1.4.5. Strategy Overview

                14.1.4.5.1. Marketing Strategy

                14.1.4.5.2. Product Strategy

                14.1.4.5.3. Channel Strategy

        14.1.5. Lexaria Bioscience Corp.

            14.1.5.1. Overview

            14.1.5.2. Product Portfolio

            14.1.5.3. Profitability by Market Segments

            14.1.5.4. Sales Footprint

            14.1.5.5. Strategy Overview

                14.1.5.5.1. Marketing Strategy

                14.1.5.5.2. Product Strategy

                14.1.5.5.3. Channel Strategy

        14.1.6. Organigram Holdings Inc.

            14.1.6.1. Overview

            14.1.6.2. Product Portfolio

            14.1.6.3. Profitability by Market Segments

            14.1.6.4. Sales Footprint

            14.1.6.5. Strategy Overview

                14.1.6.5.1. Marketing Strategy

                14.1.6.5.2. Product Strategy

                14.1.6.5.3. Channel Strategy

        14.1.7. VIVO Cannabis Inc.

            14.1.7.1. Overview

            14.1.7.2. Product Portfolio

            14.1.7.3. Profitability by Market Segments

            14.1.7.4. Sales Footprint

            14.1.7.5. Strategy Overview

                14.1.7.5.1. Marketing Strategy

                14.1.7.5.2. Product Strategy

                14.1.7.5.3. Channel Strategy

        14.1.8. The Cronos Group

            14.1.8.1. Overview

            14.1.8.2. Product Portfolio

            14.1.8.3. Profitability by Market Segments

            14.1.8.4. Sales Footprint

            14.1.8.5. Strategy Overview

                14.1.8.5.1. Marketing Strategy

                14.1.8.5.2. Product Strategy

                14.1.8.5.3. Channel Strategy

        14.1.9. AusCann Group Holdings Ltd.

            14.1.9.1. Overview

            14.1.9.2. Product Portfolio

            14.1.9.3. Profitability by Market Segments

            14.1.9.4. Sales Footprint

            14.1.9.5. Strategy Overview

                14.1.9.5.1. Marketing Strategy

                14.1.9.5.2. Product Strategy

                14.1.9.5.3. Channel Strategy

        14.1.10. Cann Group Limited

            14.1.10.1. Overview

            14.1.10.2. Product Portfolio

            14.1.10.3. Profitability by Market Segments

            14.1.10.4. Sales Footprint

            14.1.10.5. Strategy Overview

                14.1.10.5.1. Marketing Strategy

                14.1.10.5.2. Product Strategy

                14.1.10.5.3. Channel Strategy

        14.1.11. Bod Australia

            14.1.11.1. Overview

            14.1.11.2. Product Portfolio

            14.1.11.3. Profitability by Market Segments

            14.1.11.4. Sales Footprint

            14.1.11.5. Strategy Overview

                14.1.11.5.1. Marketing Strategy

                14.1.11.5.2. Product Strategy

                14.1.11.5.3. Channel Strategy

        14.1.12. Zelira Therapeutics

            14.1.12.1. Overview

            14.1.12.2. Product Portfolio

            14.1.12.3. Profitability by Market Segments

            14.1.12.4. Sales Footprint

            14.1.12.5. Strategy Overview

                14.1.12.5.1. Marketing Strategy

                14.1.12.5.2. Product Strategy

                14.1.12.5.3. Channel Strategy

        14.1.13. Althea Group

            14.1.13.1. Overview

            14.1.13.2. Product Portfolio

            14.1.13.3. Profitability by Market Segments

            14.1.13.4. Sales Footprint

            14.1.13.5. Strategy Overview

                14.1.13.5.1. Marketing Strategy

                14.1.13.5.2. Product Strategy

                14.1.13.5.3. Channel Strategy

        14.1.14. Epsilon Healthcare

            14.1.14.1. Overview

            14.1.14.2. Product Portfolio

            14.1.14.3. Profitability by Market Segments

            14.1.14.4. Sales Footprint

            14.1.14.5. Strategy Overview

                14.1.14.5.1. Marketing Strategy

                14.1.14.5.2. Product Strategy

                14.1.14.5.3. Channel Strategy

        14.1.15. MGC Pharma

            14.1.15.1. Overview

            14.1.15.2. Product Portfolio

            14.1.15.3. Profitability by Market Segments

            14.1.15.4. Sales Footprint

            14.1.15.5. Strategy Overview

                14.1.15.5.1. Marketing Strategy

                14.1.15.5.2. Product Strategy

                14.1.15.5.3. Channel Strategy

        14.1.16. ECOFIBRE

            14.1.16.1. Overview

            14.1.16.2. Product Portfolio

            14.1.16.3. Profitability by Market Segments

            14.1.16.4. Sales Footprint

            14.1.16.5. Strategy Overview

                14.1.16.5.1. Marketing Strategy

                14.1.16.5.2. Product Strategy

                14.1.16.5.3. Channel Strategy

15. Assumptions & Acronyms Used

16. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 1: North America, Europe & Asia Pacific Legal Cannabis Market Value (US$ Mn) Forecast by Region, 2017-2032

Table 2: North America, Europe & Asia Pacific Legal Cannabis Market Volume (Tons) Forecast by Region, 2017-2032

Table 3: North America, Europe & Asia Pacific Legal Cannabis Market Value (US$ Mn) Forecast by Source Type, 2017-2032

Table 4: North America, Europe & Asia Pacific Legal Cannabis Market Volume (Tons) Forecast by Source Type, 2017-2032

Table 5: North America, Europe & Asia Pacific Legal Cannabis Market Value (US$ Mn) Forecast by Derivatives, 2017-2032

Table 6: North America, Europe & Asia Pacific Legal Cannabis Market Volume (Tons) Forecast by Derivatives, 2017-2032

Table 7: North America, Europe & Asia Pacific Legal Cannabis Market Value (US$ Mn) Forecast by End-use, 2017-2032

Table 8: North America, Europe & Asia Pacific Legal Cannabis Market Volume (Tons) Forecast by End-use, 2017-2032

Table 9: North America Legal Cannabis Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 10: North America Legal Cannabis Market Volume (Tons) Forecast by Country, 2017-2032

Table 11: North America Legal Cannabis Market Value (US$ Mn) Forecast by Source Type, 2017-2032

Table 12: North America Legal Cannabis Market Volume (Tons) Forecast by Source Type, 2017-2032

Table 13: North America Legal Cannabis Market Value (US$ Mn) Forecast by Derivatives, 2017-2032

Table 14: North America Legal Cannabis Market Volume (Tons) Forecast by Derivatives, 2017-2032

Table 15: North America Legal Cannabis Market Value (US$ Mn) Forecast by End-use, 2017-2032

Table 16: North America Legal Cannabis Market Volume (Tons) Forecast by End-use, 2017-2032

Table 17: Europe Legal Cannabis Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 18: Europe Legal Cannabis Market Volume (Tons) Forecast by Country, 2017-2032

Table 19: Europe Legal Cannabis Market Value (US$ Mn) Forecast by Source Type, 2017-2032

Table 20: Europe Legal Cannabis Market Volume (Tons) Forecast by Source Type, 2017-2032

Table 21: Europe Legal Cannabis Market Value (US$ Mn) Forecast by Derivatives, 2017-2032

Table 22: Europe Legal Cannabis Market Volume (Tons) Forecast by Derivatives, 2017-2032

Table 23: Europe Legal Cannabis Market Value (US$ Mn) Forecast by End-use, 2017-2032

Table 24: Europe Legal Cannabis Market Volume (Tons) Forecast by End-use, 2017-2032

Table 25: Asia Pacific Legal Cannabis Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 26: Asia Pacific Legal Cannabis Market Volume (Tons) Forecast by Country, 2017-2032

Table 27: Asia Pacific Legal Cannabis Market Value (US$ Mn) Forecast by Source Type, 2017-2032

Table 28: Asia Pacific Legal Cannabis Market Volume (Tons) Forecast by Source Type, 2017-2032

Table 29: Asia Pacific Legal Cannabis Market Value (US$ Mn) Forecast by Derivatives, 2017-2032

Table 30: Asia Pacific Legal Cannabis Market Volume (Tons) Forecast by Derivatives, 2017-2032

Table 31: Asia Pacific Legal Cannabis Market Value (US$ Mn) Forecast by End-use, 2017-2032

Table 32: Asia Pacific Legal Cannabis Market Volume (Tons) Forecast by End-use, 2017-2032

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 1: North America, Europe & Asia Pacific Legal Cannabis Market Value (US$ Mn) by Source Type, 2022-2032

Figure 2: North America, Europe & Asia Pacific Legal Cannabis Market Value (US$ Mn) by Derivatives, 2022-2032

Figure 3: North America, Europe & Asia Pacific Legal Cannabis Market Value (US$ Mn) by End-use, 2022-2032

Figure 4: North America, Europe & Asia Pacific Legal Cannabis Market Value (US$ Mn) by Region, 2022-2032

Figure 5: North America, Europe & Asia Pacific Legal Cannabis Market Value (US$ Mn) Analysis by Region, 2017-2032

Figure 6: North America, Europe & Asia Pacific Legal Cannabis Market Volume (Tons) Analysis by Region, 2017-2032

Figure 7: North America, Europe & Asia Pacific Legal Cannabis Market Value Share (%) and BPS Analysis by Region, 2022-2032

Figure 8: North America, Europe & Asia Pacific Legal Cannabis Market Y-o-Y Growth (%) Projections by Region, 2022-2032

Figure 9: North America, Europe & Asia Pacific Legal Cannabis Market Value (US$ Mn) Analysis by Source Type, 2017-2032

Figure 10: North America, Europe & Asia Pacific Legal Cannabis Market Volume (Tons) Analysis by Source Type, 2017-2032

Figure 11: North America, Europe & Asia Pacific Legal Cannabis Market Value Share (%) and BPS Analysis by Source Type, 2022-2032

Figure 12: North America, Europe & Asia Pacific Legal Cannabis Market Y-o-Y Growth (%) Projections by Source Type, 2022-2032

Figure 13: North America, Europe & Asia Pacific Legal Cannabis Market Value (US$ Mn) Analysis by Derivatives, 2017-2032

Figure 14: North America, Europe & Asia Pacific Legal Cannabis Market Volume (Tons) Analysis by Derivatives, 2017-2032

Figure 15: North America, Europe & Asia Pacific Legal Cannabis Market Value Share (%) and BPS Analysis by Derivatives, 2022-2032

Figure 16: North America, Europe & Asia Pacific Legal Cannabis Market Y-o-Y Growth (%) Projections by Derivatives, 2022-2032

Figure 17: North America, Europe & Asia Pacific Legal Cannabis Market Value (US$ Mn) Analysis by End-use, 2017-2032

Figure 18: North America, Europe & Asia Pacific Legal Cannabis Market Volume (Tons) Analysis by End-use, 2017-2032

Figure 19: North America, Europe & Asia Pacific Legal Cannabis Market Value Share (%) and BPS Analysis by End-use, 2022-2032

Figure 20: North America, Europe & Asia Pacific Legal Cannabis Market Y-o-Y Growth (%) Projections by End-use, 2022-2032

Figure 21: North America, Europe & Asia Pacific Legal Cannabis Market Attractiveness by Source Type, 2022-2032

Figure 22: North America, Europe & Asia Pacific Legal Cannabis Market Attractiveness by Derivatives, 2022-2032

Figure 23: North America, Europe & Asia Pacific Legal Cannabis Market Attractiveness by End-use, 2022-2032

Figure 24: North America, Europe & Asia Pacific Legal Cannabis Market Attractiveness by Region, 2022-2032

Figure 25: North America Legal Cannabis Market Value (US$ Mn) by Source Type, 2022-2032

Figure 26: North America Legal Cannabis Market Value (US$ Mn) by Derivatives, 2022-2032

Figure 27: North America Legal Cannabis Market Value (US$ Mn) by End-use, 2022-2032

Figure 28: North America Legal Cannabis Market Value (US$ Mn) by Country, 2022-2032

Figure 29: North America Legal Cannabis Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 30: North America Legal Cannabis Market Volume (Tons) Analysis by Country, 2017-2032

Figure 31: North America Legal Cannabis Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 32: North America Legal Cannabis Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 33: North America Legal Cannabis Market Value (US$ Mn) Analysis by Source Type, 2017-2032

Figure 34: North America Legal Cannabis Market Volume (Tons) Analysis by Source Type, 2017-2032

Figure 35: North America Legal Cannabis Market Value Share (%) and BPS Analysis by Source Type, 2022-2032

Figure 36: North America Legal Cannabis Market Y-o-Y Growth (%) Projections by Source Type, 2022-2032

Figure 37: North America Legal Cannabis Market Value (US$ Mn) Analysis by Derivatives, 2017-2032

Figure 38: North America Legal Cannabis Market Volume (Tons) Analysis by Derivatives, 2017-2032

Figure 39: North America Legal Cannabis Market Value Share (%) and BPS Analysis by Derivatives, 2022-2032

Figure 40: North America Legal Cannabis Market Y-o-Y Growth (%) Projections by Derivatives, 2022-2032

Figure 41: North America Legal Cannabis Market Value (US$ Mn) Analysis by End-use, 2017-2032

Figure 42: North America Legal Cannabis Market Volume (Tons) Analysis by End-use, 2017-2032

Figure 43: North America Legal Cannabis Market Value Share (%) and BPS Analysis by End-use, 2022-2032

Figure 44: North America Legal Cannabis Market Y-o-Y Growth (%) Projections by End-use, 2022-2032

Figure 45: North America Legal Cannabis Market Attractiveness by Source Type, 2022-2032

Figure 46: North America Legal Cannabis Market Attractiveness by Derivatives, 2022-2032

Figure 47: North America Legal Cannabis Market Attractiveness by End-use, 2022-2032

Figure 48: North America Legal Cannabis Market Attractiveness by Country, 2022-2032

Figure 49: Europe Legal Cannabis Market Value (US$ Mn) by Source Type, 2022-2032

Figure 50: Europe Legal Cannabis Market Value (US$ Mn) by Derivatives, 2022-2032

Figure 51: Europe Legal Cannabis Market Value (US$ Mn) by End-use, 2022-2032

Figure 52: Europe Legal Cannabis Market Value (US$ Mn) by Country, 2022-2032

Figure 53: Europe Legal Cannabis Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 54: Europe Legal Cannabis Market Volume (Tons) Analysis by Country, 2017-2032

Figure 55: Europe Legal Cannabis Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 56: Europe Legal Cannabis Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 57: Europe Legal Cannabis Market Value (US$ Mn) Analysis by Source Type, 2017-2032

Figure 58: Europe Legal Cannabis Market Volume (Tons) Analysis by Source Type, 2017-2032

Figure 59: Europe Legal Cannabis Market Value Share (%) and BPS Analysis by Source Type, 2022-2032

Figure 60: Europe Legal Cannabis Market Y-o-Y Growth (%) Projections by Source Type, 2022-2032

Figure 61: Europe Legal Cannabis Market Value (US$ Mn) Analysis by Derivatives, 2017-2032

Figure 62: Europe Legal Cannabis Market Volume (Tons) Analysis by Derivatives, 2017-2032

Figure 63: Europe Legal Cannabis Market Value Share (%) and BPS Analysis by Derivatives, 2022-2032

Figure 64: Europe Legal Cannabis Market Y-o-Y Growth (%) Projections by Derivatives, 2022-2032

Figure 65: Europe Legal Cannabis Market Value (US$ Mn) Analysis by End-use, 2017-2032

Figure 66: Europe Legal Cannabis Market Volume (Tons) Analysis by End-use, 2017-2032

Figure 67: Europe Legal Cannabis Market Value Share (%) and BPS Analysis by End-use, 2022-2032

Figure 68: Europe Legal Cannabis Market Y-o-Y Growth (%) Projections by End-use, 2022-2032

Figure 69: Europe Legal Cannabis Market Attractiveness by Source Type, 2022-2032

Figure 70: Europe Legal Cannabis Market Attractiveness by Derivatives, 2022-2032

Figure 71: Europe Legal Cannabis Market Attractiveness by End-use, 2022-2032

Figure 72: Europe Legal Cannabis Market Attractiveness by Country, 2022-2032

Figure 73: Asia Pacific Legal Cannabis Market Value (US$ Mn) by Source Type, 2022-2032

Figure 74: Asia Pacific Legal Cannabis Market Value (US$ Mn) by Derivatives, 2022-2032

Figure 75: Asia Pacific Legal Cannabis Market Value (US$ Mn) by End-use, 2022-2032

Figure 76: Asia Pacific Legal Cannabis Market Value (US$ Mn) by Country, 2022-2032

Figure 77: Asia Pacific Legal Cannabis Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 78: Asia Pacific Legal Cannabis Market Volume (Tons) Analysis by Country, 2017-2032

Figure 79: Asia Pacific Legal Cannabis Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 80: Asia Pacific Legal Cannabis Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 81: Asia Pacific Legal Cannabis Market Value (US$ Mn) Analysis by Source Type, 2017-2032

Figure 82: Asia Pacific Legal Cannabis Market Volume (Tons) Analysis by Source Type, 2017-2032

Figure 83: Asia Pacific Legal Cannabis Market Value Share (%) and BPS Analysis by Source Type, 2022-2032

Figure 84: Asia Pacific Legal Cannabis Market Y-o-Y Growth (%) Projections by Source Type, 2022-2032

Figure 85: Asia Pacific Legal Cannabis Market Value (US$ Mn) Analysis by Derivatives, 2017-2032

Figure 86: Asia Pacific Legal Cannabis Market Volume (Tons) Analysis by Derivatives, 2017-2032

Figure 87: Asia Pacific Legal Cannabis Market Value Share (%) and BPS Analysis by Derivatives, 2022-2032

Figure 88: Asia Pacific Legal Cannabis Market Y-o-Y Growth (%) Projections by Derivatives, 2022-2032

Figure 89: Asia Pacific Legal Cannabis Market Value (US$ Mn) Analysis by End-use, 2017-2032

Figure 90: Asia Pacific Legal Cannabis Market Volume (Tons) Analysis by End-use, 2017-2032

Figure 91: Asia Pacific Legal Cannabis Market Value Share (%) and BPS Analysis by End-use, 2022-2032

Figure 92: Asia Pacific Legal Cannabis Market Y-o-Y Growth (%) Projections by End-use, 2022-2032

Figure 93: Asia Pacific Legal Cannabis Market Attractiveness by Source Type, 2022-2032

Figure 94: Asia Pacific Legal Cannabis Market Attractiveness by Derivatives, 2022-2032

Figure 95: Asia Pacific Legal Cannabis Market Attractiveness by End-use, 2022-2032

Figure 96: Asia Pacific Legal Cannabis Market Attractiveness by Country, 2022-2032

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Food and Beverage

Australia Legal Cannabis Market

Published : July 2022

Healthcare

Automated Cannabis Testing Market

Published : March 2019

Google translate

North America, Europe & Asia Pacific Legal Cannabis Market